Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues $ 1,254 $ 75 $ 1,536 $ 2,176
Cost of goods sold 229 132 278 1,099
Gross loss 1,025 (57) 1,258 1,077
Operating expenses:        
General and administrative 150,785 417,834 349,632 765,131
Professional fees 223,667 73,664 802,338 177,512
Depreciation expense 8,447 16,304
Total operating expenses 374,452 499,945 1,151,970 958,947
Operating loss (373,427) (500,002) (1,150,712) (957,870)
Other income (expense):        
Gain (loss) on early extinguishment of debt 4,397 (724,086) 4,397
Loss on deconsolidation of foreign subsidiaries (122,600) (220,272)
Interest income 3 3
Interest expense (369,032) (51,528) (471,011) (109,598)
Total other expense (491,632) (47,128) (1,415,369) (105,198)
Net loss (865,059) (547,130) (2,566,081) (1,063,068)
Other comprehensive loss:        
Loss on foreign currency translation (6,768) (42,328) 178,201
Net other comprehensive loss (865,059) (553,898) (2,608,409) (884,867)
Series A convertible preferred stock declared ($0.60 per share) (14,916) (15,952) (29,832) (28,725)
Net loss attributable to common shareholders $ (879,975) $ (569,850) $ (2,638,241) $ (913,592)
Weighted average number of common shares outstanding - basic 112,565,240 70,578,365 99,747,644 69,655,025
Weighted average number of common shares outstanding - diluted 112,565,240 70,578,365 99,747,644 69,655,025
Net loss per share - basic $ (0.01) $ (0.01) $ (0.03) $ (0.01)
Net loss per share - diluted (0.01) (0.01) (0.03) (0.01)
Dividends declared per share of common stock $ 0.00 $ 0.00 $ 0.00 $ 0.00